Spondyloarthropathies
Feature
What’s the Evidence Behind Popular Supplements in Rheumatology? Experts Weigh in
Many people with rheumatologic diseases try supplements for symptom relief. Here’s what you need to know about some common picks.
From the Journals
Cannabis Often Used as a Substitute for Traditional Medications
A recent cross-sectional survey showed that a considerable number of patients with rheumatic diseases switched to medical cannabis for better...
Feature
Therapeutic Drug Monitoring in Rheumatology: A Promising Outlook But Many Barriers to Overcome
Tracking patient response to DMARD therapy has the potential to improve remission, but multiple barriers must be overcome before it’s widely...
From the Journals
Fewer Recurrent Cardiovascular Events Seen With TNF Inhibitor Use in Axial Spondyloarthritis
Exposure to a TNF inhibitor reduced the risk for recurrent cardiovascular events within a month of a first event in patients with radiographic...
Feature
Direct-to-Consumer Testing’s Expansion to Rheumatology Has Benefits but Potential Risks
Rheumatologists and lab specialists generally support consumers’ ability to access tests without a doctor’s order, but they remain aware of the...
News from the FDA/CDC
Bimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial Spondyloarthritis
The drug is the first and only dual IL-17A and IL-17F inhibitor approved to treat four chronic immune-mediated inflammatory diseases.
Feature
Rheumatology Clinic Interventions for Smoking, Blood Pressure ‘Make a Big Difference’
Dr. Christie Bartels discussed how rheumatology clinics can be utilized to tackle two common risk factors for heart disease without adding...
From the Journals
Pooled Trial Data Support Lower Uveitis Rate With Bimekizumab for Axial Spondyloarthritis
In patients with axial spondyloarthritis, bimekizumab — a dual interleukin-17A/F inhibitor — showed a lower incidence rate of uveitis, suggesting...
From the Journals
Patients With Immune-Mediated Inflammatory Diseases, Type 2 Diabetes Reap GLP-1 Receptor Agonist Benefits, Too
GLP-1 RAs were associated with a decreased risk for all-cause mortality and major adverse cardiovascular events in patients with immune-mediated...
Feature
Do You Have Patients With JAKne — JAK Inhibitor–Associated Acne? Here’s What to Know
Janus kinase (JAK) inhibitor-associated acne may be overlooked outside of dermatology, experts said.
From the Journals
Chronic Back Pain in Patients With Psoriasis, Uveitis, or Colitis: How Often Is It Axial Spondyloarthritis?
A substantial proportion of patients with psoriasis, uveitis, or colitis and undiagnosed chronic back pain had axial spondyloarthritis, a study...